Takeda launches mobile application to support patient for treatment of genetic diseases By siliconindia | Friday, 26 February 2021, 12:16 Hrs Takeda India, part of the Takeda Pharmaceutical Company Limited, a global values-based, R&D-driven biopharmaceutical leader, launched the XPERT EASE application. The application is developed for the exclusive use of healthcare professionals to address awareness-related challenges and enable an efficient digital ecosystem for disease updates and dose calculation for improved management of patients with rare lysosomal storage disorders Doctors screening, diagnosis, and treatment of genetic diseases have often been identified as challenging, including advising the dosage of medicines specific to patients individual needs. The XPERT EASE is designed to keep in mind such challenges while managing lysosomal storage disorders.